Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease.
A drug described by some people as a “genius pill”for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as “chemo-brain,”according to a University of Rochester Medical Center study.
Anew way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue ? a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients.
Nina F. Schor, M.D., Ph.D., chair of the Department of Pediatrics, has spent the past two decades researching neuroblastoma, a cancer that grows from immature nerve cells. She will discuss the status of research and development of novel treatment options for the cancer, the most common solid tumor of childhood, at 4 p.m. Friday in the Case Methods Room (1-9576).
The American Heart Association/American Stroke Association has awarded two Get With the Guidelines Annual Performance Achievement Awards to Strong Memorial Hospital of the University of Rochester Medical Center for meeting its high standards for coronary artery disease and stroke care.
GlaxoSmithKline plc [LSE and NYSE: GSK] announced long-term efficacy data from a Phase II trial of a single one-week course of frontline treatment with the BEXXAR? Therapeutic Regimen (Tositumomab and Iodine I-131 Tositumomab) in 76 patients with newly diagnosed advanced follicular non-Hodgkin?s lymphoma (NHL).
GlaxoSmithKline (GSK) announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC).
As top officials from the Group of Eight (G8) industrialized countries gather in Germany for their summit meeting today, the main United Nations agency dealing with AIDS urged them to show continued leadership on the issue.
An innovative approach to tackling severe acute malnutrition ? affecting approximately 20 million children under the age of five globally ? is boosting survival rates, United Nations agencies announced jointly.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.